Biogened S.A. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported revenue was PLN 21.49 million compared to PLN 18.6 million a year ago. Net income was PLN 0.143777 million compared to PLN 0.24624 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18 PLN | +0.56% | -11.76% | -.--% |
05-15 | Biogened S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-14 | Biogened S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 11.22M | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- BGD Stock
- News Biogened S.A.
- Biogened S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022